Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation

Antibody-mediated rejection (AMR) is caused by antibodies that recognize donor human leukocyte antigen (HLA) or other targets. As knowledge of AMR pathophysiology has increased, a combination of factors is necessary to confirm the diagnosis and phenotype. However, frequent modifications to the AMR d...

Descripción completa

Detalles Bibliográficos
Autores principales: Roufosse, Candice, Becker, Jan Ulrich, Rabant, Marion, Seron, Daniel, Bellini, Maria Irene, Böhmig, Georg A., Budde, Klemens, Diekmann, Fritz, Glotz, Denis, Hilbrands, Luuk, Loupy, Alexandre, Oberbauer, Rainer, Pengel, Liset, Schneeberger, Stefan, Naesens, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163810/
https://www.ncbi.nlm.nih.gov/pubmed/35669973
http://dx.doi.org/10.3389/ti.2022.10140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163810/
https://www.ncbi.nlm.nih.gov/pubmed/35669973
http://dx.doi.org/10.3389/ti.2022.10140

Ejemplares similares